Targeting GSK3 from Ustilago maydis: Type-II Kinase Inhibitors as Potential Antifungals
- 15 May 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 7 (7) , 1257-1267
Abstract
Protein kinases are key enzymes in the complex regulation of cellular processes in almost all living organisms. For this reason, protein kinases represent attractive targets to stop the growth of eukaryotic pathogens such as protozoa and fungi. However, using kinase inhibitors to fight against these organisms bears several challenges since most of them are unselective and will also affect crucial host kinases. Here we present the X-ray structure of glycogen synthase kinase 3 from the fungal plant pathogen Ustilago maydis (UmGSK3) and its inhibition by type-II kinase inhibitors. Despite the high sequence homology between the human and the fungal variant of this vital kinase, we found substantial differences in the conformational plasticity of their active sites. Compounds that induced such conformational changes could be used to selectively inhibit the fungal kinase. This study serves as an example of how species-specific selectivity of inhibitors can be achieved by identifying and addressing the inactive state of a protein kinase. In addition to this, our study gives interesting insights into the molecular plasticity of UmGSK3 by revealing a previously unknown inactive conformation of this important kinase family.Keywords
This publication has 40 references indexed in Scilit:
- A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targetsBritish Journal of Pharmacology, 2012
- A Chemical Genetic Approach for Covalent Inhibition of Analogue-Sensitive Aurora KinaseACS Chemical Biology, 2012
- Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitorNature Chemical Biology, 2011
- Identification of Ustilago maydis Aurora Kinase As a Novel Antifungal TargetACS Chemical Biology, 2011
- Trypanosoma brucei Glycogen Synthase Kinase-3, A Target for Anti-Trypanosomal Drug Development: A Public-Private Partnership to Identify Novel LeadsPLOS Neglected Tropical Diseases, 2011
- Proteus in the World of Proteins: Conformational Changes in Protein KinasesArchiv der Pharmazie, 2010
- Evaluation of phenylaminopyrimidines as antifungal protein kinase inhibitorsPest Management Science, 2005
- Fungicide activity through activation of a fungal signalling pathwayMolecular Microbiology, 2004
- Protein kinases as targets for anti-parasitic chemotherapyBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2004
- A Myristoyl/Phosphotyrosine Switch Regulates c-AblCell, 2003